company logo
Epigeneres Biotech is an early cancer-detection startup.
Basic Information
Epigeneres Biotech offering is working to transform the way cancer care is delivered with real-time, comprehensive and swift insights. In May 2021, Epigeneres Biotech announced their early detection cancer test (co-developed with Tzar Labs, Singapore - a specialised molecular diagnostic company), with a pioneering breakthrough in RNA bio-markers technology which can even detect cancer in Stage Zero (i.e., before tumour formation). The startup is working towards expanding its lab facilities, scaling operations, and development of an AI platform to launch the service in India - a world first. And, continue bringing the best diagnostic technology to patients and providers.
Legal Name
:
Epigeneres Biotech Private Limited
Headquarters
:
Mumbai, Maharashtra , India
Founding Date
:
2008
No. of Employees
:
41 to 60
Core Team
:
1.  
Ashish Tripathi
Founder & Chairman
2.  
Anish Tripathi
Managing Director
3.  
Vinay Kumar Tripathi
Chairman
Funding

Total Funding

$6.0M

Investors
:
1.  
Moez Daya
2.  
Chockalingam Valliappa
3.  
Ashish Kacholia
4.  
Kotak Investment Advisors

See More

Detail Round Breakdown
Round 1

$6M

Series Name
:
SERIES-B
Date
:
18th Jan 2022
Investors
:
1.  
Kotak Investment Advisors
2.  
LetsVenture
3.  
Moez Daya
4.  
East River Advisors

See More